scispace - formally typeset
I

Itaru Endo

Researcher at Yokohama City University

Publications -  853
Citations -  18116

Itaru Endo is an academic researcher from Yokohama City University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 57, co-authored 711 publications receiving 12954 citations.

Papers
More filters
Journal ArticleDOI

Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).

Masamichi Yokoe, +59 more
TL;DR: Thorough literature search about diagnostic criteria for acute cholecystitis, new and strong evidence that had been released from 2013 to 2017 was not found with serious and important issues about using TG13 diagnostic criteria of acute CholecyStitis, and the TG13 severity grading has been validated in numerous studies.
Journal ArticleDOI

Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.

Kohji Okamoto, +58 more
TL;DR: In the Tokyo Guidelines 2018 (TG18) as discussed by the authors, the authors proposed a flowchart for the treatment of acute cholecystitis (AC) in advanced centers with specialized surgeons experienced in this procedure.
Journal ArticleDOI

Biomarkers for the early diagnosis of hepatocellular carcinoma.

TL;DR: An overview of the biomarkers that are currently used for the early diagnosis of hepatocellular carcinoma (HCC) is provided in this article, where the most promising biomarkers, such as glypican-3, osteopontin, Golgi protein-73 and nucleic acids including microRNAs, are most likely to become clinically validated in the near future.
Journal ArticleDOI

Tokyo Guidelines 2018 surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos)

TL;DR: It is absolutely necessary to avoid any increase in bile duct injury (BDI), particularly vasculo‐biliary injury (VBI), which is known to occur at a certain rate in LC.
Journal ArticleDOI

Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.

Harumi Gomi, +58 more
TL;DR: The Tokyo Guidelines 2018 provides recommendations for the appropriate use of antimicrobials for community‐acquired and healthcare‐associated infections and the duration of antimicrobial therapy for both acute cholangitis and cholecystitis is systematically reviewed.